Compounds > r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid
Page last updated: 2024-09-03

r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and Neurodegenerative Diseases

r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid has been researched along with Neurodegenerative Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolstoe, SE; Wood, SP1

Reviews

1 review(s) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and Neurodegenerative Diseases

ArticleYear
Drug targets for amyloidosis.
    Biochemical Society transactions, 2010, Volume: 38, Issue:2

    Topics: Amyloidosis; Animals; Carboxylic Acids; Cross-Linking Reagents; Drug Delivery Systems; Humans; Models, Biological; Models, Molecular; Neurodegenerative Diseases; Prealbumin; Protein Binding; Protein Multimerization; Pyrrolidines; Serum Amyloid P-Component

2010